The Brazilian government has announced an agreement with Oxford University and pharmaceutical company AstraZeneca to produce a promising coronavirus vaccine that is undergoing tests.
Brazilian Health Ministry authorities said in a news conference on Saturday that the country will pay $127m and receive material to produce 30.4 million doses in two batches in December and January, which would allow it to quickly start inoculation efforts if the vaccine is certified to be safe and effective.
The total deal is for 100 million vaccines for a country of about 210 million residents. It will be produced by local vaccine maker Fiocruz.
British researchers started testing the experimental shot in May aiming to immunise more than 10,000 people, including older people and children. The vaccine is one of about a dozen in the early stages of human testing.
Brazil, where coronavirus infections are still on the rise, counts more than one million confirmed cases and more than 55,900 fatalities.